fbpx Skip to content
ACT-AD Clinical Trial
  • Home
ACT-AD Clinical Trial
  • Home

Study underway on take-home drug for Alzheimer’s patients

May 17, 2021

View the story on the WPBF website.

Posts navigation

← Dr. David Greeley, MD, FAAN, founder of Northwest Neurological, focuses on the details of clinical trials and what they mean for you and your family.

About ACT-AD
Open Label Extension (ATH-1017 Study 203)
Study Locations
What to Expect
Resources
Contact

Trial sponsored by  
clinicaltrials@athira.com

©2022 Athira Pharma | Privacy Policy

Scroll To Top